Bio-Key International Inc (NASDAQ:BKYI) has a beta value of 0.34 and has seen 1.46 million shares traded in the last trading session. The company, currently valued at $3.81M, closed the last trade at $1.22 per share which meant it gained $0.12 on the day or 10.91% during that session. The BKYI stock price is -201.64% off its 52-week high price of $3.68 and 57.38% above the 52-week low of $0.52.

Bio-Key International Inc (NASDAQ:BKYI) trade information

Sporting 10.91% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BKYI stock price touched $1.22 or saw a rise of 5.43%. Year-to-date, Bio-Key International Inc shares have moved -28.65%, while the 5-day performance has seen it change 19.61%. Over the past 30 days, the shares of Bio-Key International Inc (NASDAQ:BKYI) have changed -1.61%.

Bio-Key International Inc (BKYI) estimates and forecasts

The company’s shares have gained 8.93% over the past 6 months.

1 analysts offering their estimates for the company have set an average revenue estimate of 2.29M for the current quarter. 1 have an estimated revenue figure of 2.5M for the next ending quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 32.10% over the past 5 years.

BKYI Dividends

Bio-Key International Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.27% shares in the company for having 8.55 shares of worth $10433.0 while later fund manager owns 6.65 shares of worth $8116.0 as of Dec 31, 2024 , which makes it owner of about 0.21% of company’s outstanding stock.